Daily MedNews
Printable Version   Email to a friend

Neighborhood Alcohol Outlets Tied to Kids' Injury Risk

THURSDAY, Sept. 4 -- The more places that sell alcohol in a neighborhood, the greater the number of injuries that occur to children who live there, a new study reports.

The findings, published in the November issue of Alcoholism: Clinical & Experimental Research, are based on analyzing data from 1,646 California zip code areas and local hospital discharges for childhood injuries, assaults and injuries related to child abuse from 2000.

"First, greater densities of off-premise alcohol outlets may increase the frequency of drinking among parents at home, undermining their ability to adequately supervise their children's activities," Bridget Freisthler, an assistant professor in the department of social welfare at the University of California, Los Angeles, said in a news release issued by the journal's publisher. "Second, greater densities may increase the number of people who travel in and out of the neighborhood to shop or dine at restaurants, making it more difficult for residents to know who lives in the area and who is just conducting business there. Thus, other adults in the area may be less likely to intervene when they see unsupervised children playing."

The study was a joint project between UCLA and the Prevention Research Center, Pacific Institute for Research and Evaluation, where Freisthler is an affiliated research scientist.

"This study shows that the effects of high concentrations of alcohol outlets are more far reaching than previously thought," she said. "Specific findings indicate that costs associated with injuries among children could be reduced if outlet densities were more carefully controlled. It is important to emphasize that these injuries are only one measurable outcome of the kind of lack of supervision and support that seems to occur in these disordered neighborhoods with high alcohol-outlet densities."

Richard Scribner, D'Angelo Professor of Alcohol Research at the Louisiana State University School of Public Health, agreed. "One's neighborhood environment determines the number and type of risks a resident of a particular neighborhood will be exposed to. This study supports the conceptual model that views the neighborhood environment as an essential component in contributing to population health."

Freisthler said she hopes her findings will lead to tougher decisions about licensing and locating alcohol outlets in neighborhoods.

"They affect the quality of life, the relationships among neighbors, levels of crime, and the safety of all of us. Obviously, we want policy makers to pay attention to these findings. But they are also important for average citizens to understand," she said.

More information

Safe Kids USA has more about children and safety.


Latest Daily MedNews...

Daily MedNews Archive

2008: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov
2007: Jul | Aug | Sep | Oct | Nov | Dec

More News Resources


MedNotes
Latest FDA Drug Alerts
November 17, 2008
Audience: Consumers, dermatologists, pharmacists, other healthcare professionals[Posted 11/17/2008] CSI USA Inc. and FDA informed...
November 12, 2008
Audience: Consumers, pediatricians, other healthcare professionals[Posted 11/12/2008] Johnson & Johnson, Merck Consumer...
November 12, 2008
Audience: Geriatricians, gynecologists, orthopedic surgeons, other healthcare professionals[Posted 11/12/2008] FDA issued an...
November 10, 2008
Audience: Pharmacists, other healthcare professionals, patients [Posted 11/10/2008] Ethex Corp and FDA notified healthcare...
More...
Latest Drug Information Updates

Apriso
Apriso (mesalamine) is a once-daily, locally-acting aminosalicylate indicated for the maintenance of remission of ulcerative colitis (UC) in adults.

LoSeasonique
LoSeasonique is a lower-dose, extended-cycle oral contraceptive indicated for the prevention of pregnancy.

Acanya
Acanya (benzoyl peroxide and clindamycin phosphate) is a topical antibacterial and antibiotic combination for the treatment of acne.

Toviaz
Toviaz (fesoterodine fumarate) is a competitive muscarinic receptor antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.

Vimpat
Vimpat (lacosamide) is an anti-convulsant drug for the treatment of partial onset seizures in adults with epilepsy.

Astepro
Astepro (azelastine) is a nasal antihistamine for the treatment of seasonal allergic rhinitis.

Rapaflo
Rapaflo (silodosin) is an alpha(1)- adrenoreceptor antagonist for the treatment of the signs and symptoms associated with benign prostatic hyperplasia (BPH), or enlarged prostate.

Cinryze
Cinryze is a C1-esterase inhibitor indicated for routine prophylaxis against angioedema attacks in adolescent and adult patients with Hereditary Angioedema (HAE).

Akten
Akten (lidocaine hydrochloride) Ophthalmic Gel is a topical, ocular anesthetic formulation for use in ocular procedures that require a topical anesthetic agent.

AdreView
AdreView is a diagnostic radiopharmaceutical agent indicated for use in the detection of rare neuroendocrine tumors in children and adults.

Sancuso
Sancuso (granisetron transdermal system) is an anti-emetic transdermal delivery system indicated for the control of nausea and vomiting in patients receiving moderately and/or highly nausea-inducing chemotherapy.

Nplate
Nplate (romiplostim) is a thrombopoietin mimetic peptibody for the treatment of thrombocytopenia in adult patients with chronic immune (idiopathic) thrombocytopenic purpura (ITP).

Xenazine
Xenazine (tetrabenazine) is a selective and reversible centrally-acting dopamine depleting drug indicated for the treatment of chorea associated with Huntington's disease.

Cleviprex
Cleviprex is an intravenous, ultrashort-acting calcium channel blocker under development for the treatment of severely elevated blood pressure in the hospital setting when oral therapy is not feasible or desirable.

Stavzor
Stavzor is delayed-release valproic acid formulated in the EnteriCare enteric soft gelatin capsule delivery system designed to minimize GI adverse events. Stavzor is indicated for the treatment of manic episodes associated with bipolar disorder, adjunctive therapy in multiple seizure types (including epilepsy), and prophylaxis of migraine headaches.

More...